Evidence map›Paper›PMID 42344827›Full record

ArticleCureus2026

Primary Cutaneous Nodular Amyloidosis Presenting As Violaceous Patches on Bilateral Plantar Feet.

Madeline A LaRow, Paul K Vance, Michael Hohnadel

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Madeline A LaRowDermatology, Kirksville College of Osteopathic Medicine, Kirksville, USA.
Paul K VanceDermatology, Corpus Christi Medical Center, Corpus Christi, USA.
Michael HohnadelDermatology, Corpus Christi Medical Center, Corpus Christi, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary localized cutaneous amyloidosis (PLCA) is characterized by amyloid deposition limited to the skin and is subdivided into macular, lichenoid, and nodular variants. Primary cutaneous nodular amyloidosis (PCNA) is the rarest subtype and typically presents as waxy, firm nodules or plaques composed of immunoglobulin light chain-derived (AL-type) amyloid. Plantar involvement is exceedingly uncommon. We report the case of a 64-year-old Hispanic man found incidentally to have bilateral, well-demarcated, flat violaceous patches on the plantar surfaces of both feet. The lesions were asymptomatic, non-nodular, and lacked overlying epidermal change. Histopathologic examination revealed amorphous eosinophilic deposits within the dermis, which stained positive with Congo red and exhibited apple-green birefringence under polarized light, confirming amyloid deposition. The patient was diagnosed with PCNA, presenting with atypical patch-like morphology, and managed conservatively with close clinical surveillance. This case represents an unusual clinical presentation of PCNA, diverging from the classic nodular phenotype and mimicking inflammatory or granulomatous dermatoses. To our knowledge, this is among the first reported cases of plantar PCNA presenting as flat violaceous patches rather than nodules. Given the potential risk of progression to systemic amyloidosis, accurate diagnosis and ongoing monitoring remain essential. Awareness of this expanded clinical spectrum underscores the importance of histopathologic evaluation in atypical acral dermatoses and may help prevent misdiagnosis or delayed recognition of this rare entity.

Indexed as

amyloidosisapple-green birefringencecongo red stainingnodular amyloidosisunusual acral dermatosesviolaceous patch

Identifiers

PMID42344827
PMCPMC13290016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.